用Fosaprepitant治疗的大麻素过度减肥综合征:一个案例报告
Markus D Moore1,2, Saeed K Alzghari1, Andrew N Soliman1
1Pharmacy, Texas Health Harris Methodist Hospital Fort Worth, Fort Worth, USA.
Cureus
|September 22, 2025
概括
加拿大大麻使用者中,大麻类过度吸收综合征 (CHS) 会引起严重的恶心和吐. 本案例研究探讨了在标准治疗失败时,用于难以治疗的CHS症状的fosaprepitant的使用.
科学领域:
- 医学科学 医学科学 医学科学
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 加拿大大麻药超综合征 (CHS) 具有慢性大麻使用者的反复恶心和吐的特点.
- CHS可能导致严重脱水,电解质失衡和住院治疗.
- 对CHS症状的标准治疗包括液体复苏和抗药物.
研究的目的:
- 报告一个成功治疗难治性大麻素过度复杂综合征 (CHS) 的病例.
- 评估福萨普雷皮坦在治疗与CHS相关的耐火性恶心和吐方面的疗效.
主要方法:
- 一份病例报告,详细说明CHS患者的临床表现和治疗.
- 在常规抗emetic疗法失败后,使用fosaprepitant.
- 监测患者的症状和对治疗的反应.
主要成果:
- 尽管接受了标准治疗,但患者还是出现了难以治愈的恶心和吐.
- 施用佛萨普雷皮坦导致症状显著缓解.
- 患者的病情有所改善,没有与fosaprepitant相关的不良事件.
结论:
- 佛萨普雷皮坦可能是一个可行的治疗选择,用于严重的,耐火性大麻素过度复杂综合征.
- 需要进一步的研究来证实福萨普雷皮坦在CHS管理中的有效性和安全性.
- 这一案例凸显了新型治疗方法对挑战性CHS病例的潜力.
更多相关视频
相关概念视频
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
1.0K
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
1.0K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
935
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
935
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
827
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
827
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.2K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.2K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
1.1K
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
1.1K
Pharmaceutical Poisoning: Treatment Strategies
285
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
285


